Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O5YZ
|
|||
Former ID |
DIB013577
|
|||
Drug Name |
Mepindolol
|
|||
Synonyms |
Mepindolol Bio Tsd; PH-851; Mepindolol, Pharmed/SB
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Angina pectoris [ICD-11: BA40; ICD-9: 413] | Approved | [1] | |
Company |
Pharmed Dr Liedtke GmbH
|
|||
Structure |
Download2D MOL |
|||
Formula |
C15H22N2O2
|
|||
Canonical SMILES |
CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)C)O
|
|||
InChI |
1S/C15H22N2O2/c1-10(2)16-8-12(18)9-19-15-6-4-5-14-13(15)7-11(3)17-14/h4-7,10,12,16-18H,8-9H2,1-3H3
|
|||
InChIKey |
NXWGWUVGUSFQJC-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 23694-81-7
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:135082
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adrenergic receptor beta-3 (ADRB3) | Target Info | Modulator | [1], [2], [3] |
KEGG Pathway | Calcium signaling pathway | |||
cGMP-PKG signaling pathway | ||||
Neuroactive ligand-receptor interaction | ||||
Endocytosis | ||||
Salivary secretion | ||||
Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
Beta3 adrenergic receptor signaling pathway | ||||
Reactome | Adrenoceptors | |||
G alpha (s) signalling events | ||||
WikiPathways | Monoamine GPCRs | |||
Calcium Regulation in the Cardiac Cell | ||||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 2 | Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol. Arzneimittelforschung. 1986 May;36(5):811-3. | |||
REF 3 | Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.. Br J Clin Pharmacol. 1982; 13(Suppl 2): 187S-192S. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.